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Dopaminergic projections to the striatum, crucial for the correct functioning of this brain region in adulthood, are known to be estab-
lished early in development, but their role is currently uncharacterized. We demonstrate here that dopamine, by activating D1- and/or
D2-dopamine receptors, decreases the number of functional GABAergic synapses formed between the embryonic precursors of the
medium spiny neurons, the principal output neurons of the striatum, with associated changes in spontaneous synaptic activity. Activa-
tion of these receptors reduces the size of postsynaptic GABAA receptor clusters and their overall cell-surface expression, without
affecting the total number of clusters or the size or number of GABAergic nerve terminals. These changes result from an increased
internalization of GABAA receptors, and aremediated by distinct signaling pathways converging at the level of GABAA receptors to cause
a transient PP2A/PP1-dependent dephosphorylation. Thus, tonic D1- and D2-receptor activity limits the extent of collateral inhibitory
synaptogenesis between medium spiny neurons, revealing a novel role of dopamine in controlling the development of intrinsic striatal
microcircuits.
Introduction
The striatum, as the central part of the basal ganglia, integrates
excitatory inputs from the cortex and thalamus with dopaminer-
gic inputs from the substantia nigra pars compacta (SNpc), and
sends projections to the output nuclei. It is composed primarily
of GABAergic medium spiny projection neurons (95–98%), and
a small number of GABAergic interneurons and cholinergic neu-
rons (5% of all neurons) (Tepper and Bolam, 2004). Inhibition
of medium spiny neurons is largely intrinsic to the striatum and
occurs primarily via a feedforward mechanism mediated by the
interneurons (Tepper and Bolam, 2004; Mallet et al., 2005), and
to some extent by a feedback mechanism between projection
neurons (Guzma´n et al., 2003; Taverna et al., 2008). The essential
molecular mediators of both mechanisms are GABAA receptors,
members of a diverse family of heteropentameric GABA-gated
chloride channels, which can be assembled from seven classes of
homologous subunits: (1–6), (1–3), (1–3), , , , and 
(Whiting, 2003). GABAA receptors are highly concentrated at
synaptic sites apposed to presynaptic GABA-releasing terminals
in the striatum (Fujiyama et al., 2000), and are likely to be dy-
namically regulated by the lateral migration to extrasynaptic sites
(Thomas et al., 2005), internalization and reinsertion (Kittler et
al., 2000, 2004), and direct phosphorylation (Brandon et al.,
2002; Jovanovic et al., 2004) as reported in other brain regions.
The essential role of dopamine in a wide range of psychomo-
tor functions of the adult striatum has been extensively charac-
terized in both health and disease, and shown to be mediated
through the activation of D1- and D2-like dopamine receptors
(D1Rs and D2Rs) (Seeman and Van Tol, 1994). Thus, dopamine
receptors regulate the activity of striatal neurons (Aosaki et al.,
1998; Bracci et al., 2002), GABAergic currents (Yan and Surmeier,
1997; Flores-Hernandez et al., 2000), and glutamatergic synapse
numbers (Day et al., 2006). In contrast, the role of dopamine in
the developing striatum is unknown despite the evidence that
dopaminergic inputs from the SNpc are formed as early as em-
bryonic day 12 (E12) in rats (Voorn et al., 1988; Gates et al.,
2006). Nevertheless, a developmental role for dopamine has been
suggested by observations following in utero exposure to cocaine,
which, via activation of dopamine receptors (Jones et al., 2000;
Stanwood and Levitt, 2007), has profound effects on the devel-
opment of dendrites (Jones et al., 1996; Levitt et al., 1997) and
expression of GABAA receptors (Lu et al., 2009). Given that em-
bryonic striatal neurons express both D1Rs and D2Rs (Aizman et
al., 2000), we sought to assess whether these receptors regulate
GABAergic synaptogenesis in the developing striatum.
We demonstrate that dopamine receptor activity decreases
the number of GABAergic synapses formed between striatal neu-
rons in vitro, by causing a reduction in the size ofGABAA receptor
clusters and their overall cell-surface expression. These changes
are mediated by distinct D1R and D2R signaling pathways con-
Received Sept. 7, 2009; revised Jan. 8, 2010; accepted Jan. 15, 2010.
This work was supported by the Biotechnology and Biological Sciences Research Council UK New Investigator
Grant BB/C507237/1 (to J.N.J.) and a Novartis-funded PhD studentship (to D.G.). We thank Dr. Tom McAvoy,
Laura Maruca, and Anya Sihra-Jovanovic for technical assistance, and Dr. Talvinder Sihra for critical reading of
this manuscript.
Correspondence should be addressed to Dr. Jasmina N. Jovanovic, Department of Pharmacology, The School of
Pharmacy, University of London, Brunswick Square, London WC1N 1AX, UK. E-mail: jasmina.jovanovic@
pharmacy.ac.uk.
DOI:10.1523/JNEUROSCI.4411-09.2010
Copyright © 2010 the authors 0270-6474/10/302935-16$15.00/0
The Journal of Neuroscience, February 24, 2010 • 30(8):2935–2950 • 2935
verging at the level of GABAA receptors to trigger their transient
PP2A/PP1-dependent dephosphorylation. Thus, by altering the
levels of cell-surface expression of GABAA receptors, dopamine
exerts a powerful control of inhibitory synaptogenesis in the de-
veloping striatum.
Materials andMethods
Immunohistochemistry. Whole-brain specimens were isolated from E17
Sprague Dawley rats and fixed overnight in 4% paraformaldehyde, 0.1%
glutaraldehyde, and 0.2% saturated picric acid solution in 0.1 M phos-
phate buffer (PB), pH 7.2, at 4°C. For cryoprotection, brains were im-
mersed in increasing concentrations of sucrose/PBS (10%, 20%, and
30%) until submerged, at 4°C. Brain specimens were frozen, and 20 m
sections were cut through themidbrain–hindbrain region. Sections were
washed with PBS and incubated with 0.3 M glycine/PBS to quench PFA.
For permeabilization and reduction of nonspecific binding, sections
were incubated in 1% BSA/ 0.1% Triton X-100/PBS for 30 min. Sections
were incubated with a rabbit anti-tyrosine hydroxylase antibody (1:1000
dilution, Merck Biosciences), or mixture of mouse anti-D1R (1:100 dilu-
tion, Abcam) and rabbit anti-D2R (5g/ml,Millipore) antibodies in PBS
overnight at 4°C. Primary antibodies were visualized after staining with
the appropriate goat anti-rabbit and anti-mouse IgGs conjugated to
Alexa555 and Alexa488, respectively (3 g/ml, Millipore Bioscience Re-
search Reagents), in 1% BSA/PBS for 60 min. Sections were washed and
coverslips mounted using Vectashield (Vector). Immunoreactivity was
visualized using laser scanning confocal microscope (Zeiss LSM 510
Meta) with5 objective or63 oil-immersion objective.
HPLC analysis of tissue dopamine levels. Embryonic striata were
promptly dissected and weighed before being flash-frozen and stored at
80°C. Individual tissue samples were then placed in ice-cold PBS and
homogenized. All homogenates were treated with 0.1 M perchloric acid
(1:10, w/v) containing ascorbic acid (0.2 M) and EDTA (0.2 M), to
precipitate cell debris. These were then centrifuged at 13,000 g for 15
min at 4°C. The supernatant was passed through a syringe filter (10 m
pore size), andwhole-tissue dopamine levels were estimated usingHPLC
with electrochemical detection (Biggs et al., 1992). Dopamine peak areas
were quantified using an external standardmethod, and dopamine levels
expressed as amount of dopamine in nanomoles per milligram of total
protein content, with protein levels measured using BCA assay (Thermo
Fisher Scientific).
Cell cultures. Primary striatal neuronal cultures were prepared as de-
scribed previously (Ventimiglia and Lindsay, 1998) with minor modifi-
cations. Briefly, striata were dissected from E16–E17 Sprague Dawley
rats, dissociated by trituration in Ca2- andMg2-freeHEPES-buffered
saline solution (HBSS; Invitrogen), plated at a density of 100,000 cells per
cm2 in Neurobasal medium, containing B27 supplement, glutamine
(2 mM), penicillin (100 U), streptomycin (100 g), and glucose (6
mM; all from Invitrogen) on either 0.1 mg/ml poly-D-lysine-coated
culture dishes or 0.1mg/ml poly-L-lysine-coated glass coverslips. Cul-
tures were incubated in a humidified 37°C/5% CO2 incubator for 7 or
14 d before experimentation.
Immunocytochemistry. Striatal neurons cultured at a density of 100,000
cells/cm2 were treated with vehicle, the D1R agonist SKF-38393 (1 nM),
or the D2R agonist quinpirole (100 nM; both from Tocris Bioscience) for
72 h (from4 to 7 d in vitro, DIV) or 7 d (from7 to 14DIV), before fixation
with 4% paraformaldehyde/4% sucrose/PBS for 15 min. Cultures were
washed and incubated with 1% BSA/0.5% Triton X-100/PBS for 30 min
to permeabilize cells and reduce nonspecific binding. Cultures were in-
cubated with mouse anti-D1R (1:100 dilution, Abcam) and rabbit anti-
D2R (5g/ml,Millipore) antibodies in PBS overnight at 4°C. For analysis
of GABAergic synapses, cultures were first incubated with the GABAA
receptor 2/3 subunit-specific primary antibody (MAB341, bd17 clone,
10g/ml,Millipore Bioscience Research Reagents) in 1%BSA/PBS over-
night (14–16 h) at 4°C without permeabilization. Cultures were then
washed with PBS and cells permeabilized with 0.5% Triton X-100/PBS
for 30min, followed by incubationwith 1%BSA/PBS for 30min to block
nonspecific binding. Cultures were incubated with rabbit anti-vesicular
inhibitory amino acid transporter (VIAAT) antibody [1:1000, kindly
provided by Dr. A. Dumoulin and Prof. A. Triller, Inserm U497, Ecole
Normale Supe´rieure, Paris, France (Dumoulin et al., 2000)] or glutamic
acid decarboxylase (GAD) 65 (1:1000, Millipore Bioscience Research
Reagents) in 1%BSA/PBS for 60min. Primary antibodies were visualized
after staining with the appropriate goat anti-mouse and anti-rabbit IgG
conjugated to Alexa555 and Alexa488, respectively (3 g/ml, Millipore
BioscienceResearchReagents), in 1%BSA/PBS for 60min.Cultureswere
washed and coverslips mounted using Vectashield (Vector). Immunore-
activity was visualized using laser scanning confocal microscope (Zeiss
LSM 510Meta) with a63 oil-immersion objective. In each image, laser
light levels and detector gain and offset were adjusted to avoid any satu-
rated levels.
Quantification of punctum area, number, and colocalization. For each
treatment, a minimum of 6–10 randomly selected neurons were exam-
ined in at least three independent experiments. For these experiments,
the number, area, and colocalization of puncta were determined from
confocal images using the LSM5 Image program. Immunoreactive
puncta were defined as immunoreactivity 0.1 m2 present along the
first 20 m length of primary processes (Yu et al., 2007). Threshold for
each channel in each image was calculated as the mean pixel intensity for
the entire image plus two SDs above the mean. Puncta colocalization in
two different fluorescence channels was determined by overlaying the
images. A punctum in the red channel was considered to colocalize with
a punctum in the green channel, resulting in a yellow color, when50%
or more of the surface of one punctum overlapped with the other punc-
tum. Colocalization was analyzed by determining the percentage of in-
dividual 2/3 subunit-positive puncta along the first 20 m length of
primary processes that were in close apposition to (and thus partially
overlap with) VIAAT-1 or FM1-43FX-immunoreactive puncta. Values
are expressed as mean SEM (number of cells). Statistical analysis was
performed using a two-tailed t test (Graphpad Prism 4.0).
FM1-43FX uptake. To assess the functionality of GABAergic neurons,
we determined the uptake of the aldehyde-fixable styryl dye FM1-43FX
(Invitrogen) (Sara et al., 2002; Brumback et al., 2004). Uptake of FM1-
43FXwas performed as previously described with someminormodifica-
tions (Ting et al., 2006). Following treatment with dopamine receptor
agonists as described in the previous section, cells were briefly washed
twice with buffer A (mM: 149 NaCl, 4 KCl, 1.5 CaCl2, 1.5 MgCl2, 10
glucose, and 10 HEPES, pH 7.4). Cultures were then incubated at 37°C
with 100 M bicuculline, 100 M picrotoxin, 50 M D-AP5, and 10 M
CNQX (all from Tocris Bioscience) diluted in buffer A. Cultures were
further incubated in 60 mM K solution (in mM: 69 NaCl, 60 KCl, 1.5
CaCl2, 1.5 MgCl2, 10 glucose, and 10 HEPES, pH 7.4) containing FM1-
43FX (10 M) for 2 min. Excess styryl dye was effectively removed by
washing three times in cold buffer A (4°C) for 1min, followed bywashing
twice with ADVASEP-7 (500 M, Sigma-Aldrich) for 2 min (Kay et al.,
1999). Cultures were subsequently washed in buffer A with a low con-
centration of K to remove FM1-43FX/ADVASEP-7 at 4°C without
causing exocytosis of vesicles loaded with FM1-43FX dye. Cells were
fixed in 4% paraformaldehyde/4% sucrose/PBS and processed for im-
munocytochemistry using anti-2/3 antibody, followed by goat anti-
mouse IgG conjugated to Alexa555 (3 g/ml) as described above.
Immunoreactivity was visualized using a Zeiss LSM 510Meta laser scan-
ning confocal microscope with a63 oil-immersion objective.
Electrophysiology.Whole-cell recordings were made from striatal neu-
rons in culture, treated with the vehicle, SKF-38393 (1 nM), or quinpirole
(100 nM) for up to 30 min, or for 72 h (4–7 DIV), as described above.
Neuronswere visualized using videomicroscopy under near-infrared dif-
ferential interference contrast (DIC) illumination. Experiments were
conducted at 20–22°C. Patch pipettes (resistance 8–10M) were pulled
from borosilicate glass tubing and filled with an internal solution con-
taining the following (in mM): 144 K-gluconate, 3 MgCl2, 0.2 EGTA, 2
Na2-ATP, 0.2 Na2-GTP, and 10 HEPES, pH 7.2–7.4, 300 mOsm. Spon-
taneous activity of the neurons was recorded in current-clamp mode
(SEC 05L/H, npi electronics) in the presence of TTX (1 M), D-AP5 (50
M), and CNQX (20M, all from Tocris Bioscience). Synaptic potentials
recorded were amplified, low-pass filtered at 2 kHz, and digitized at 5
kHz using a CED 1401 interface and data acquisition program, Signal
4.04 (Cambridge Electronic Design). Electrophysiological recordings
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were later analyzed offline using Signal. Individual sweeps were observed
manually and measurable IPSPs were taken from values 0.05 mV in
peak amplitudes. Miniature IPSP amplitudes (measured from the base-
line to the peak of the IPSP) and rise times (10–90%) were measured
from individual synaptic events. Average amplitudes are given asmean
SD obtained from 100–250 frames of 1 s duration. Events 0.05 mV
were related to the baseline noise without any measurable amplitudes or
rise times. The data illustrated in Figure 3 are individual single sweep raw
data that have not been smoothed, and illustrate a high signal-to-noise
ratio.
Internalization assay. Cell-surface receptors were tagged in living cul-
tured neurons with the primary antibody against 2/3 subunits as de-
scribed previously (van Rijnsoever et al., 2005). Briefly, coverslips were
incubated with ice-cold buffer A (in mM: 150 NaCl; 3 KCl; 2 MgCl2; 10
HEPES, pH 7.4; and 5 glucose), containing 0.35 M sucrose for 5 min to
inhibit receptor internalization, followed by incubationwithmouse anti-
2/3 antibody (MAB341, 10 g/ml, Millipore Bioscience Research Re-
agents) for 60 min at 4°C in buffer A containing 0.35 M sucrose, 1 mM
EGTA, and 1% BSA. Excess antibody was removed by washing in the
same medium. Cultures were returned to the incubator (at 37°C) in
buffer A containing 1mMCaCl2, 5 mM glucose, and 5g/ml leupeptin in
the absence or presence of SKF-38393 (1 nM) or quinpirole (100 nM) for
30 min to allow internalization of the tagged 2/3 subunit-containing
GABAA receptors. Cultures were then fixed for 15 min using 4% para-
formaldehyde/4% sucrose/PBS, extensively washed with PBS, and incu-
bated in 1% BSA/PBS for 30 min to reduce nonspecific binding. To label
GABAA receptors remaining at the cell surface, cultures were incubated
with goat anti-mouse IgG conjugated to Alexa555 (3 g/ml, Millipore
BioscienceResearchReagents) overnight (14–16 h) at 4°C. Cultureswere
extensively washed with PBS, and cells were permeabilized and nonspe-
cific binding blocked for 30 min using 1% BSA/PBS containing 0.5%
Triton X-100. To label internalized GABAA receptors, cultures were in-
cubated with goat anti-mouse IgG conjugated to Alexa488 (3 g/ml,
Millipore Bioscience Research Reagents) for 60min at the room temper-
ature. Cultures were washed extensively and coverslips mounted using
Vectashield. Immunoreactivity was visualized as described above using a
Zeiss LSM 510 Meta laser scanning confocal microscope.
Determination of GABAA receptor cell-surface levels using ELISA.
Changes in surface and total levels of GABAA receptors were analyzed
using a cell-surface ELISA assay as described previously (Noel et al., 1999;
Bedford et al., 2001; Jovanovic et al., 2004). Striatal neurons were cul-
tured in 24-well plates at a density of 100,000 cells/cm2. Following both
short (up to 2 h) and long (up to 7 d) treatments with vehicle, SKF-38393
(1 nM), or quinpirole (100 nM) as described in the figure legends, cultures
were washed with PBS and fixed using 4% paraformaldehyde/4% su-
crose/PBS for 15 min. The fixative was removed by extensive washing
with PBS followed by HBSS (Invitrogen). Nonspecific cell-surface bind-
ing of antibody was reduced by incubating cultures for 30 min in 1%
BSA/10% rabbit serum/HBSS. In those cultureswhere total protein levels
were evaluated, cells were permeabilized and nonspecific binding
blocked by incubating with 0.5% Triton/1% BSA/10% rabbit serum/
HBSS for 30 min. Cultures were incubated with anti-2/3 antibody (1
g/ml) overnight at 4°C. After extensive washing and nonspecific bind-
ing block as described above, cultures were incubated with anti-mouse
IgG conjugated to horseradish peroxidase (HRP, 1:2500, Pierce) for 60
min. Cultures were extensively washed and a color substrate 3,3,5,5-
tetramethylbenzidine (TMB; Sigma-Aldrich) reagent added for 20 min
until sufficient color reaction had developed. Absorbances were read at
	 	 655 nm using a spectrophotometer (Duo 800, Beckman Coulter).
Controlswere routinely usedwithoutusingprimary antibody todetermine
background levels of peroxidase and nonspecific binding of secondary anti-
body. Values are expressed as mean SEM (number of experiments, each
done in duplicate). Statistical analysis was performed using one-way
ANOVA with Dunnett post hoc analysis and two-tailed t test (Graphpad
Prism 4.0).
In vitro phosphorylation. Glutathione S-transferase (GST) fusion pro-
teins encoding the intracellular transmembrane domain 3–4 loops of
GABAA receptor 1-3 subunits were purified from Escherichia coli as
described previously (McDonald andMoss, 1997; Jovanovic et al., 2004).
The catalytic subunit of PKAwas purified from bovine heart as described
previously (Kaczmarek et al., 1980). Phosphorylation of GST-1, -2,
and -3 used the incubation conditions described for the catalytic sub-
unit of PKA (Huttner et al., 1981), in the presence of 150 M ATP, with
trace amounts of [- 32P]ATP, to yield a final stoichiometry of 0.4, 0.4,
and 1.1 molP/mol protein, respectively. Incorporation of 32P was deter-
mined using measurement of Cerenkov radiation. The phosphorylated
proteinswere repurified usingNICKcolumns (GEHealthcare).Dopamine-
and cAMP-regulated phosphoprotein (Mr 	 32,000; DARPP-32), phos-
phorylated byPKA to a stoichiometry of 0.3molP/mol of protein (Girault et
al., 1989)andphosphorylasea (Cohenetal., 1988),werephosphorylatedand
repurified as described.
In vitro dephosphorylation. Protein phosphatase 1 catalytic subunit
(PP1c, Mr 	 37,000) and protein phosphatase 2A (PP2A, complex of
catalytic and regulatory subunit, Mr 	 96,000) were purchased (Milli-
pore), and calcineurin (Mr	 76,000) was purified from rat brain (Nairn
et al., 1995). Purified phosphatases were assayed in 50 mM Tris-HCl, pH
7.0, 15 mM 2-mercaptoethanol, and 1 mg/ml BSA at 30°C, as described
previously (Desdouits et al., 1998), in the presence of 0.3% Brij-35 and
0.3 mM EGTA in the case of PP1c and PP2A, or 100 M CaCl2 and 1 M
calmodulin in the case of calcineurin. Reactions were started by the ad-
dition of substrate and terminated by the addition of 200l of 20% (w/v)
trichloroacetic acid. After the further addition of 50 l of 10 mg/ml
bovine serum albumin, samples were centrifuged for 5 min at room
temperature at 17,000 g, and the amount of 32P in the supernatant and
the pellet was determined by measurement of Cerenkov radiation. PP1c
and PP2A activities were measured using 1 M [32P] phosphorylase a as
substrate (Ingebritsen et al., 1983) under initial rate conditions (the re-
lease of phosphate was linear with time and enzyme concentration, and
corresponded to 25% of the phosphate incorporated into the sub-
strate). For measurements of calcineurin activity, initial rate conditions
were determined using 1M [32P] phospho-DARPP-32. Under the same
conditions, PP1c-, PP2A-, and calcineurin-mediated dephosphorylation
of different [ 32P]-labeled phospho-GST-1-3 subunits (1 M) was di-
rectly compared to that of standard substrates (phosphorylase a and
DARPP-32) (Table 1). Data represent the means of three independent
experiments, each done in duplicate. For kinetic analysis, dephosphory-
lation assays were done using increasing concentrations of phospho-
substrates (GST-1: 0.6–10 M; GST-2: 0.4–2 M; and GST-3: 0.1–1
M). The total amount of PP1c andPP2Aper reactionwas 2.5 ng. TheKm
and Vmax values were calculated from linear regression analysis of
Lineweaver-Burk transformations of data describing the initial rates of
dephosphorylation as a function of substrate concentration, and repre-
sent themeans of three independent experiments, each done in duplicate
(Table 2).
Treatments with protein kinase and phosphatase inhibitors. For cell-
surface ELISA experiments, E17 embryonic striatal cultures (7DIV)were
treatedwith SKF-38393 (1 nM), quinpirole (100 nM), or dopamine (1M)
for 30minwith the exception of time course experiments. Those cultures
that received treatment with SCH-23390 (1 M), sulpiride (1 M),
8-bromo-cAMP (10 M), forskolin (10 M), fostriecin (1 M), and oka-
daic acid (100 nM or 1M; all from Tocris Bioscience), calphostin C (200
nM), and PD-98059 (50 M, both from Calbiochem), were treated for 10
min before the addition of dopamine receptor agonists; all others were
Table 1. GABAA receptor subunit dephosphorylation by purified protein
phosphatases
Dephosphorylation (% 32P removed)
PP1c PP2Ac PP2B
1 24.8 6.9 35.9 1.5 2.1 1.2
2 15.6 5.2 31.3 1.3 3.9 3.7
3 15.7 3.9 27.1 1.1 0.4 0.2
Ref. subst. 23.5 9.6 (Phosphoryl. a) 17.0 3.6 (Phosphoryl. a) 33.1 13.6 (DARPP32)
The activities of purified PP1, PP2A, and calcineurin were measured under initial rate conditions using 1M
32P-labeled 1-3 subunits of GABAA receptors as described (see Materials and Methods). Relative rates of
dephosphorylation were expressed as a percentage of total 32P released in the presence of a phosphatase in
5 min. Phospho-1-3 incubated in the absence of phosphatases served as control. Data represent the mean
of three independent experiments done in duplicate.
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treated with vehicle during this time. Those cultures treated with EGTA
(1 mM, Sigma-Aldrich) or BAPTA-AM (25 M, Calbiochem) received a
30 min treatment before dopamine receptor agonists; all others received
vehicle during this time.
Immunoblotting. E17 embryonic striatal cultures (7 DIV) were treated
with SKF-38393 (1 nM), quinpirole (100 nM), or both for 5 min to 2 h.
Those cultures that received treatment with PD-98059 (50 M), fostrie-
cin (1 M), or okadaic acid (1 M) were treated for 10 min before the
addition of dopamine receptor agonists for 10 min; all others were
treated with vehicle during this time. Samples were lysed with 1% SDS
and protein concentration determined using BCA assay. Samples with
the same amount of total protein were separated using SDS-PAGE and
transferred onto a nitrocellulose membrane. Nonspecific binding was
blocked by incubation of membranes with TBS/Tween buffer containing 2
mg/ml BSA. Membranes were incubated with rabbit anti-phospho-
subunit antibody purified against a phospho-Ser409-peptide column (Jo-
vanovic et al., 2004) or rabbit total 3 antibody (0.5 g/ml, Phosphosolu-
tions, Aurora, CO), for 90 min, followed by washing with TBS/Tween.
Membranes incubated with the total 3 antibody were blocked using TBS/
Tween buffer containing 1.5% (w/v) powdered milk. Membranes were in-
cubated with [125I]-anti-rabbit polyclonal antibody (GEHealthcare) for 60
min, and washed as before using TBS/Tween buffer. Detection of immuno-
reactivity was performed using a phosphoimager (Molecular Devices).
Results
Dopaminergic projections and dopamine receptors are
present in the embryonic E17 striatum
In the ontogeny of the rat, dopaminergic fibers positive for ty-
rosine hydroxylase (TH) arrive in the striatal enlarge on E14
(Specht et al., 1981; Voorn et al., 1988). To establish the presence
of dopaminergic system in the embryonic rat (E17) striatum in
vivo, whole-brain sections cut through the midbrain–hindbrain
region were stained using antibodies specific for TH, D1R, and
D2R. Prominent TH fibers and terminal-like staining were de-
tected at this stage of development (Fig. 1A). The expression of
dopamine D1R and D2R, and a high degree of colocalization be-
tween these receptors, was also observed throughout the embry-
onic striatum (Fig. 1B). The levels of tissue dopamine were
measured in acutely prepared homogenates using HPLC, reveal-
ing 11.4 0.5 nmol of dopamine permilligramof total protein in
E17 and 14.4  0.6 nmol of dopamine per milligram of total
protein in E18 striatal tissue. In contrast, levels of tissue nor-
adrenaline and 5-HT were below detection in these experiments.
Dopamine receptor activation decreases the number of
GABAergic synapses and the size of GABAA receptor clusters
Embryonic striatal neurons in vitro form a highly homogenous
population of precursors of GABAergic medium spiny neurons
that display a number of properties that are similar to their in vivo
counterparts; they form functional GABAergic synapses, express
D1Rs and D2Rs, and display similar electrophysiological proper-
ties (Bockaert et al., 1986; Aizman et al., 2000; Falk et al., 2006).
The coexpression of D1R andD2R demonstrated in vivo (Fig. 1B)
was also detected in vitro, where all the neurons imaged showed a
strong immunoreactivity for both receptors at 7 DIV (Fig. 2A)
and 14 DIV (Fig. 2B). To examine whether dopamine regulates
the extent of synaptic connectivity between these neurons, we
used confocal microscopy to analyze the number of GABAergic
synapses upon the application of SKF-38393, a D1R-specific ag-
onist, or quinpirole, a D2R-specific agonist. Localization of
VIAAT-1, a presynaptic marker of GABAergic and glycinergic
synapses (Dumoulin et al., 1999) was found to completely overlap
with that of GAD-65, a presynaptic marker specific for GABAergic
synapses (data not shown). As these presynaptic markers colocalize
with surface-expressed GABAA receptor 2/3 subunit clusters, re-
flecting the close apposition between the presynaptic and postsyn-
aptic components ofGABAergic synapses (Chih et al., 2005;Dong et
al., 2007; Yu et al., 2007), we estimated the number of these synapses
along defined length of primary neuronal processes.
Upon treatment with SKF-38393 (1 nM) or quinpirole (100
nM) for 72 h or 7 d, we observed a significant decrease in the
colocalization between GABAA receptor 2/3 subunit clusters ex-
pressed at the cell-surface and VIAAT-1-positive presynaptic ter-
minals: 79.6 3.0% of surface 2/3 subunit clusters, which were
colocalized with VIAAT-1 puncta in control cultures (7 DIV),
was significantly decreased to 50.1  3.7% ( p  0.01, paired t
test,n	 26) by 72 h treatmentwith SKF-38393, or to 49.8 3.6%
( p 0.01, paired t test, n	 21) by 72 h treatmentwith quinpirole
(Fig. 2C,E). Similarly, a prolonged 7 d treatment of cells (from
7 to 14 DIV) with either of the agonists resulted in a significant
decrease in colocalization between 2/3 subunit clusters and
VIAAT-1-positive presynaptic terminals: 90.6  1.2% colocal-
ization observed in control vehicle-treated cells was significantly
reduced to 68.0  2.4% ( p  0.01, paired t test, n 	 24) by
SKF-38393, and to 70.0 3.0% ( p 0.01, paired t test, n	 21)
by quinpirole (Fig. 2D,F). Thus, both D1Rs and D2Rs decrease
the number of GABAergic synapses formed between embryonic
precursors of medium spiny neurons in vitro.
The observed reduction in the number ofGABAergic synapses
may occur due to a reduction in the number of presynaptic
GABAergic terminals or postsynaptic GABAA receptor clusters,
or inhibition of the formation and maintenance of synaptic con-
tacts. Alternatively, these changes may result from changes in the
structure of presynaptic or postsynaptic elements. To evaluate
these possibilities, we performed detailed quantitative analysis of
the area and the number of 2/3 puncta and VIAAT-1 puncta
along the initial 20 m of primary neuronal processes following
dopamine receptor activation.
Our analysis revealed a significant decrease in the area of sur-
face 2/3-positive puncta following dopamine receptor activa-
tion. In control cells cultured for 7 DIV, the area of 2/3 subunit
puncta was 0.45  0.04 m2, which was significantly decreased
to 0.29 0.02m2 ( p 0.001, paired t test, n	 26), or to 0.31
0.03m2 ( p 0.001, paired t test,n	 21) by 72 h treatmentwith
SKF-38393 or quinpirole, respectively (Fig. 2G,I, 72 h). Dopa-
mine receptor activation produced similar effects in cells cultured
for 14 DIV: in control cells, the area of 2/3 subunit puncta was
0.67 0.04m2 compared to 0.46 0.03m2 after SKF-38393
treatment ( p  0.001, paired t test, n 	 24) for 7 d and 0.48 
0.03 m2 after 7 d treatment with quinpirole ( p 0.001, paired
t test, n	 21) (Fig. 2H, I, 7 d). However, we observed no signif-
icant change in the number of 2/3 puncta at the cell surface
following activation of either D1Rs or D2Rs for 72 h or 7 d. In
control cells cultured for 7 DIV, there were 5.31  0.31 2/3
subunit puncta compared to 5.59  0.29 in those treated with








1 1.6 0.9 2.7 0.5 0.4 0.1 5.0 0.5
2 3.8 2.9 22.2 15.9 0.8 0.5 3.2 0.5
3 0.06 0.01 2.2 0.2 0.14 0.08 2.5 0.6
The activities of purified PP1 and PP2Aweremeasured under initial rate conditions for 5 min using various concen-
trations of 32P-labeled1-3 subunits as described (seeMaterials andMethods). Phospho-1-3 subunits incubated
in the absence of phosphatases served as control. Kinetic parameters were calculated from linear regression of
Lineweaver-Burk plots, each representing the mean of three independent experiments, each done in duplicate.
2938 • J. Neurosci., February 24, 2010 • 30(8):2935–2950 Goffin et al. • Dopamine Regulates Formation of Striatal GABAergic Synapses
SKF-38393 ( p  0.05, paired t test, n 	 26) and 5.36  0.26 in
those treatedwith quinpirole for 72 h ( p 0.05, paired t test, n	
21) (Fig. 2K, 72 h). The number of 2/3 subunit puncta in neu-
rons cultured for 14 DIV was 7.25  0.28 in control cells and
7.43  0.30 in those treated with SKF-38393 for 7 d ( p  0.05,
paired t test, n 	 24) and 7.83  0.41 in those treated with
quinpirole for 7 d ( p 0.05, paired t test, n	 21) (Fig. 2K, 7 d).
To assess changes in presynaptic GABAergic terminals, we ana-
lyzed the area and the number of VIAAT-1-positive puncta. There
was no significant change in the area of VIAAT-1 puncta following
72 h treatment with SKF-38393 or quinpirole: the average area of
puncta in vehicle-treated cells was 0.49 0.03 m2 in comparison
with 0.45 0.06m2 in SKF-38393-treated ( p 0.05, paired t test,
n	 26) or 0.49 0.05m2 in quinpirole-treated ( p 0.05, paired
t test,n	21) cultures (Fig. 2G,J, 72h). Similar resultswere obtained
in cultures treated for 7 dwith SKF-38393 or quinpirole: the average
area of puncta in vehicle-treated cells was 0.56 0.03m2 in com-
parison with 0.55 0.03 m2 in SKF-38393-treated ( p  0.05,
paired t test, n 	 24) or 0.57  0.04 m2 in quinpirole-treated
( p  0.05, paired t test, n 	 24) cultures
(Fig. 2H, J, 7 d). The number of VIAAT-
positive puncta also remained unchanged
during 72 h treatment with SKF-38393 or
quinpirole: vehicle-treated cells had
5.33  0.30 puncta compared to 5.20 
0.30 in SKF-treated ( p  0.05, paired t
test, n 	 24) and 5.31  0.29 in
quinpirole-treated ( p  0.05, paired t
test, n	 21) cultures (Fig. 2L, 72 h). Sim-
ilarly, the number of VIAAT-positive
puncta in controls (6.47 0.19, p 0.05,
paired t test, n	 24) remained unchanged
during 7 d treatment with SKF-38393
(6.57  0.30, p  0.05, paired t test, n 	
24) or quinpirole (6.49  0.30, p  0.05,
paired t test, n	 24) (Fig. 2L, 7 d).
To assess whether the observed dopa-
mine receptor-mediated changes in mor-
phology correlated with changes in the
number of functional GABAergic synapses,
we used confocal microscopy to analyze the
degree of colocalization between GABAer-
gic terminals labeled by activity-dependent
uptake of aldehyde-fixable styryl dye FM1-
43FX (Sara et al., 2002), and GABAA recep-
tor 2/3 subunit clusters. We demonstrate
that colocalization between surface 2/3-
and FM1-43FX-positive puncta was sig-
nificantly decreased from 68.1 2.6% in
control conditions to 42.3  3.1% ( p 
0.01, paired t test, n	 26) following 72 h
treatment with SKF-38393, and to 45.6
3.2% ( p  0.01, paired t test, n 	 21)
following treatment with quinpirole (Fig.
3A,B). Prolonged 7 d treatment of cells
(from 7 to 14 DIV) with either of ago-
nists also resulted in a significant decrease
in colocalization between surface 2/3- and
FM1-43FX-positive puncta: 75.9  1.8%
observed in control conditions was signifi-
cantly decreased to 36.6  2.4% ( p  0.01,
paired t test,n	 24) upon the treatmentwith
SKF-38393, and to 35.8  2.6% ( p  0.01,
paired t test,n	 21) upon the treatmentwith quinpirole (Fig. 3C).
We performed whole-cell patch-clamp analysis of striatal neu-
rons to measure spontaneous activity at inhibitory synapses (mIP-
SPs) in response to application of dopamine receptor agonists. We
demonstrate that cultured embryonic striatal neurons exhibit mIP-
SPs with an amplitude of 1.8 0.2mV and a frequency of 2.3 0.2
Hz (n	 6) (Fig. 3D–F). These spontaneous currentswereGABAer-
gic since they were completely eliminated by the addition of picro-
toxin (50 M) to the perfusion bath (Fig. 3D, left, picrotoxin).
Following 72 h treatment with SKF-38393, the amplitudes and fre-
quencyofmIPSPswere significantlydecreased compared to control:
amplitudes ofmIPSPs were 0.9 0.3mV, and frequency was 1.4
0.2Hz ( p 0.05, two-tailed t test, n	 4) (Fig. 3D–F). The remain-
ing spontaneous currents in SKF-38393-treated cultures were also
completely inhibited by picrotoxin (Fig. 3D, right, picrotoxin).
The amplitudes and frequency of mIPSPs were also reduced in cul-
tures treated for 72 h with quinpirole (Fig. 3E,F). However, short
treatments (up to 30min)with SKF also reduced the amplitude and
frequency ofmIPSPs in these cultures from2.0 1.0mV and 3.0
Figure 1. Dopaminergic projections and dopamine receptors are present in the embryonic striatum. A, Dopaminergic projec-
tions positive for TH (5, scale bar corresponds to 200m) form a prominent network of fibers in the ventral part of the striatal
enlargement, while terminal-like staining (63, scale bars correspond to 20m) is abundant in the dorsal part of the embryonic
(E17) striatum. B, Dopamine D1 receptors and D2 receptors are expressed throughout the whole striatal enlargement and show a
high-degree of colocalization (63, scale bars correspond to 20m).
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Figure 2. Dopamine receptor activation decreases the colocalization of postsynaptic GABAA receptor2/3 subunit puncta with presynaptic VIAAT-1 puncta. Embryonic striatal neurons express
both D1Rs and D2Rs when cultured for 7 d (7 DIV) (A), and 14 d (14 DIV) (B). Scale bars correspond to 20m. Striatal cultures were treated for 72 h (from 4 to 7 DIV) (C) or 7 d (from 7 to 14 DIV) (D)
with vehicle, SKF-38393, or quinpirole, and stained for GABAAR2/3 subunit (in red) and VIAAT-1 (in green). Scale bars correspond to 10m. The percentage of2/3 subunit-positive puncta that
colocalizedwithVIAAT-1punctawas significantly decreased in cultures treatedwith SKF-38393or quinpirole for 72h (E) or 7d (F ).G,H, Relative cumulative frequencyplots of2/3-immunoreactive
puncta and VIAAT-1-positive puncta (in square micrometers) measured along a defined length of primary processes (20m) following the treatment with vehicle (Figure legend continues.)
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0.8Hz, respectively, in vehicle-treated cultures, to 0.9 0.7mVand
0.6 0.4 Hz ( p 0.05, two-tailed t test, n	 4, data not shown).
Similar effects were observed following short treatments with quin-
pirole: amplitudes and frequenciesofmIPSPswere reduced from3.2
0.4mVand3.20.8Hzinvehicle-treatedcultures to1.60.3mVand
1.3 0.3 Hz, respectively ( p 0.05, two-tailed t test, n	 3, data not
shown). These data provide further evidence that bothD1Rs andD2Rs
decrease the number of functional GABAergic synapses formed be-
tween embryonic precursors ofmedium spinyneurons.
Dopamine receptors decrease cell-surface expression of
GABAA receptors
The reduction in size of GABAA receptor 2/3 subunit-positive
clusters at the cell surface observed upon activation of D1Rs and
D2Rs may be occurring due to increased lateral diffusion from
synaptically clustered receptor pools to more diffuse extrasynap-
tic pools (Thomas et al., 2005), without an overall decrease in the
total surface numbers. Alternatively, it may reflect an overall re-
duction in their number at the cell surface, without changing a
balance between clustered and diffuse receptors. To distinguish
between these twomechanisms, wemeasured the cell-surface levels
of GABAA receptor 2/3 subunits using cell-surface ELISA assays
(Noel et al., 1999; Bedford et al., 2001; Jovanovic et al., 2004).
We demonstrate that D1R activation by SKF-38393 led to a
significant and prolonged decrease in the surface expression of
GABAA receptors, which was observed as early as 10 min upon
the application of the drug and maintained for up to 7 d in the
continuous presence of the drug (one-way ANOVA; with Dun-
nett post hoc analysis; n 	 4) (Fig. 4A, in black): surface 2/3
subunit levels were reduced to 82.4 6.2% of vehicle ( p 0.05)
after 10min, to 81.3 3.5%of vehicle ( p 0.05) after 30min; to
82.9 5.6% ( p 0.05) of vehicle after 60 min; to 80.4 5.9%
( p  0.05) of vehicle after 120 min; to 82.4  3.1% of vehicle
( p 0.01) after 72 h, and to 80.8 5.2% of vehicle ( p 0.05)
after 7-d-long treatment with SKF-38393. D1R activation had no
significant effect on the total levels of 2/3 subunits at any of those
time points tested (Fig. 4A, in gray). The effects of SKF-38393
(88.1 1.9%of vehicle-treated controls) were blocked by the appli-
cation of D1R antagonist SCH-23390 (101.3  4.8% of vehicle-
treated control, p 0.05, paired t test, n	 6) (Fig. 4C).
4
(Figure legend continued.) (white), SKF-38393 (black), or quinpirole (dark gray) for 72h(4–7
DIV, left) (G) or 7 d (7–14 DIV, right) (H). I, SKF-38393 (black) and quinpirole (gray) significantly
decreased the average 2/3 subunit punctum area in comparison with controls (vehicle treated,
white) cells, following treatments for 72 h or 7 d. J, SKF-38393 (black) and quinpirole (gray) had no
effect on the average VIAAT-1 punctum area in comparison with controls (vehicle treated, white),
following treatments for 72 h or 7 d. K, The total number of 2/3-positive puncta remained un-
changedfollowingthetreatmentwithvehicle(white),SKF-38393(black),orquinpirole(gray)for72hor7d.
L, ThetotalnumberofVIAAT-1-positivepuncta remainedunchangedfollowingthetreatmentwithvehicle
(white), SKF-38393 (black), or quinpirole (gray) for 72 h or 7 d. Bars represent mean SEM. Statistical
analysiswasperformedusingpaired ttest:***p0.001.
Figure 3. Dopamine receptor activation decreases the number of functional GABAergic synapses. A, Cultures were treated for 72 h (from 4 to 7 DIV) with vehicle, SKF-38393, or quinpirole,
followed by activity-dependent labelingwith FM1-43FX. Scale bars correspond to 10m. SKF-38393 and quinpirole significantly decreased the colocalization of2/3 puncta (in red) and FM1-43FX
puncta (in green) after treatment for 72 h (from 4 to 7 DIV, B), or 7 d (from 7 to 14 DIV, C). Bars represent mean SEM. Statistics was performed using t test: ***p 0.001.D, mIPSPs recorded in
striatal neurons after 72h treatment (from4 to7DIV)with vehicle (control) or SKF-38393 in thepresence of TTX (1M), D-AP5 (50mM), andCNQX (20mM), before andafter bath application of GABAA
receptor antagonist picrotoxin (50 M, picrotoxin). Three representative traces for each condition are shown. Scale refers to all four conditions. E, F, SKF-38393 and quinpirole treatments
decreased the amplitude (E) and frequency (F) of mIPSPs. Bars represent mean SD. Statistical analysis was performed using two-tailed t test: *p 0.05.
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We also examined the effects of D2R ac-
tivation by quinpirole on GABAA receptor
surface levels using cell-surface ELISA ap-
proach. Quinpirole decreased the surface
expression of2/3 subunits to 94.0 1.1%
following 10 min treatment ( p  0.05); to
83.8  2.0% after 30 min treatment ( p 
0.01), to 91.6 2.0% after 60 min treatment
( p0.05);to84.17.2%after120mintreat-
ment ( p 0.01), to 85.4 3.2% after 72 h




fect on the total levels of 2/3 subunits at any
of time points tested (Fig. 4B, in gray). The
decrease observed after 30 min treatment
with quinpirole (74.0  6.3% of control)
was prevented by the D2R antagonist
sulpiride (93.9 2.9% of control, p 0.05,
paired t test, n	 4) (Fig. 4D).
Furthermore, we demonstrate that the
application of dopamine (1M) also caused
a prominent reduction in the cell-surface
expression of GABAA receptors via activa-
tion of both D1Rs and D2Rs. Significantly,
the decrease in surface 2/3 subunit levels
to 75.6 2.3% of vehicle-treated controls
was partially attenuated to 86.7 4.3% of
vehicle-treated controls in the presence of
D1R antagonist SCH-23390 (1 M), and to
84.7  3.9% of vehicle-treated controls in
thepresence ofD2Rantagonist sulpiride (10
M, p 0.05, one-way ANOVAwith Dun-
nett post hoc analysis; n	 5) (Fig. 4E).
Although both D1Rs and D2Rs appear
to mediate regulation of GABAA receptor
cell-surface levels by dopamine, application
of specific receptor agonists SKF-38393 (1
nM) and quinpirole (100 nM) at the same
time resulted in a reduction in surface 2/3
subunit levels to 71.4  7.7% of vehicle-
treated controls, which was slightly but not significantly more pro-
nounced than theapplicationofSKF-38393 (81.33.5%ofvehicle-
treated control) or quinpirole alone (83.8 2.0%of vehicle-treated
control, p 0.05, one-way ANOVAwith Dunnett post hoc analysis;
n 	 4) (Fig. 4F). Thus, both D1R and D2R activation leads to a
significant and prolonged decrease in cell-surface levels of GABAA
receptors in embryonic striatal neurons.
Dopamine receptor activation enhances GABAA
receptor endocytosis
GABAA receptors are continuously internalized by clathrin-
dependent endocytosis and replaced by insertion of newly synthe-
sized receptors (Kittler et al., 2000). To examine whether dopamine
receptor activation leads to an increase in GABAA receptor endocy-
tosis, we visualized this process using immunocytochemistry (van
Rijnsoever et al., 2005). Cultured striatal neurons were incubated
with the same anti-2/3 subunit antibody as in cell-surface ELISA
experiments to label GABAA receptors at the cell surface. Cultures
were subsequently treated with vehicle, SKF-38393 (1 nM), or quin-
pirole (100 nM) for 30 min. Following fixation, GABAA receptors
remaining at the cell surfacewere probedwith a secondary antibody
conjugated toAlexa555 (Fig. 5A,B, in red). Followingpermeabiliza-
tion, the internalized receptors were probed with a secondary anti-
body conjugated to Alexa488 (Fig. 5A,B, in green). The two pools
were analyzed using confocal microscopy. We demonstrate that
both treatments increased theamountof internalizedGABAArecep-
torswith a concomitant reduction in those located at the cell surface
relative to vehicle-treated controls (Fig. 5A,B). A small amount of
internalized2/3 subunits observed inneurons treatedwithvehicle is
likely to be due to the constitutive internalization of GABAA recep-
tors (van Rijnsoever et al., 2005).
To investigate these processes further, we performed cell-
surface ELISA assays in the presence of an inhibitory peptide that
specifically prevents clathrin-dependent endocytosis by blocking
the binding of dynamin to amphiphysin (Gout et al., 1993; Grabs
et al., 1997; Lissin et al., 1998; Marks andMcMahon, 1998; Nong
et al., 2003). This peptide (DynP) significantly attenuated the
ability of SKF-38393 to decrease surface 2/3 subunit levels from
86.5  2.2% of control to 96.6  2.1% ( p  0.05, paired t test;
n	 4) (Fig. 5C), and quinpirole from 88.1 1.2% of control to
95.6 2.0% of control ( p 0.01, paired t test; n	 4) (Fig. 5D).
In contrast, the scrambled control version of this peptide
Figure 4. Activation of dopamine receptors decreases the cell-surface expression of GABAA receptors. A, SKF-38393 (1 nM)
caused a significant and prolonged decrease in the level of2/3 subunits (black) expressed at the cell surface, but not in total levels
of these subunits (gray).B, Quinpirole (100nM) caused a significant andprolongeddecrease in2/3 subunit cell-surface expression
(black) but not in their total levels (gray). C, D1R antagonist SCH-23390 (1M, SCH) abolished the reduction in surface2/3 levels
upon 30 min treatment with SKF-38393 (1 nM, SKF). D, D2R antagonist sulpiride (10 M, Sulp) significantly attenuated the
reduction in surface2/3 levels upon 30min treatment with quinpirole (100 nM, Q). E, Dopamine (1M, DA)-dependent decrease
in the2/3 subunit surfacewas significantly attenuatedbySCH-23390 (DASCH), and sulpiride (DASulp), indicating thatboth
D1Rs and D2Rsmediate the effects of dopamine. F, Activation of both D1Rs and D2Rs by their respective agonists (SKFQ) caused
a reduction in surface 2/3 levels comparable to changes observed upon the treatment with SKF-38393 (SKF) or quinpirole (Q)
alone. Bars represent mean SEM. Statistical analysis was performed using one-way ANOVA with either a Dunnett post hoc
analysis versus control (*p 0.05; **p 0.01), or paired t test ( #p 0.05).
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(DynPC) had no significant effect (Fig. 5C,D). SKF-38393 or
quinpirole had no effect on total 2/3 levels (102.3  2.7% of
control), and this was unaffected by the presence ofDynP (97.9
4.6% of control) or DynPC (97.0  5.7% of control; p  0.05,
paired t test; n 	 4; data not shown). These results indicate that
both D1Rs and D2Rs mediate the reduction in the cell-surface
expression of 2/3 subunit-containing GABAA receptors, at least
in part, through an increase in dynamin-mediated endocytosis.
D1Rs and D2Rs activate distinct signaling pathways to reduce
cell-surface levels of GABAA receptors
D1Rs andD2Rs are coexpressed in the embryonic precursors ofme-
dium spiny neurons both in vivo and in vitro (Figs. 1, 2) (Aizman et
al., 2000). Furthermore, both receptor types are activated by do-
pamine to control the formation of inhibitory synapses and reg-
ulate cell-surface expression of GABAA receptors. Although
evidently impinging on the same functional target, these recep-
tors are likely to activate distinct signaling cascades in these neu-
rons (Greengard, 2001). We used specific activators and
inhibitors of a number of intracellular signaling molecules to
characterize these signaling cascades.
cAMP/PKA signaling
D1Rs and D2Rs are classified by their positive or negative cou-
pling to Gs or Gi/o G-proteins that regulate adenylyl cyclase (AC);
it is this coupling that is responsible for a
large number of downstream cellular ef-
fects (Missale et al., 1998). To determine
whether AC mediates regulation of sur-
face GABAA receptors by D1Rs or D2Rs,
we examined the effects of forskolin, an ac-
tivator ofAC (Awad et al., 1983; Laurenza et
al., 1989). Neurons were pretreated with
vehicle or forskolin (10 M) for 10 min,
after which D1Rs and D2Rs were activated
with SKF-38393 (1 nM) or quinpirole (100
nM) in the absence or presence of forsko-
lin. Changes in the surface and total levels
of2/3 subunits were examined using cell-
surface ELISA. We demonstrate that fors-
kolin treatment alone caused an apparent
increase in 2/3 surface levels to 108.2 
3.3%of control, although this was not sta-
tistically significant ( p  0.05, one-way
ANOVA; n	 4; data not shown). The de-
crease in surface 2/3 levels after 30 min
treatment with SKF-38393 (83.5  3.1%
of control, p  0.05, one-way ANOVA;
n 	 4) (Fig. 6A, SKF) was significantly
attenuated by forskolin (98.5  5.1% of
control, p 0.05; paired t test; n	 4) (Fig.
6A, SKF/F). In contrast, the decrease ob-
served in the presence of quinpirole
(85.2  3.9% of control, p  0.05, one-
way ANOVA; n 	 5) (Fig. 6A, Q) was
unaffected (88.4  4.3% of control, p 
0.05, one-way ANOVA; n 	 5) (Fig. 6A,
Q/F) by the presence of forskolin. Forsko-
lin had no significant effect on the total
levels of 2/3 subunits in the absence
(105.8  4.4% of control, p  0.05, one-
way ANOVA; n	 4) or presence of SKF-
38393 (113.5 3.2% of control; p 0.05,
one-way ANOVA; n 	 4) or quinpirole
(105.1 5.1%of control, p 0.05, one-wayANOVA; n	 5, data
not shown). These results suggest that stimulation of AC by for-
skolin occludes the ability of D1Rs to activate AC and regulate
GABAA receptor levels, without affecting the D2R-dependent
regulation of these receptors.
To testwhether PKAparticipates as a downstreamcomponent
of D1R/AC signaling cascade, we treated striatal neurons with the
selective PKA activator 8-bromo-cAMP (10 M) in the absence
or presence of SKF-38393 (1 nM) or quinpirole (100 nM) for 30
min. Direct activation of PKA with 8-bromo-cAMP caused a
small but significant increase in the surface expression of 2/3
subunit to 112.8 4.0% of control ( p 0.05, one-way ANOVA
with Dunnett post hoc test; n	 5; data not shown), and abolished
(101.4 3.1% of control, p 0.05; paired t test; n	 5) (Fig. 6B,
SKF/cAMP) the SKF-38393-dependent decrease in 2/3 levels to
89.0 2.9% of control ( p 0.05; one-way ANOVA with Dun-
nett post hoc analysis; n 	 5) (Fig. 6B, SKF). However,
quinpirole-dependent decrease in surface 2/3 levels (81.0 
7.3% of control, p  0.05, one-way ANOVA with Dunnett post
hoc analysis; n 	 4) (Fig. 6B, Q) was unaffected by 8-bromo-
cAMP (82.6 6.3% of control, p 0.05, one-way ANOVA with
Dunnett post hoc analysis; n 	 4) (Fig. 6B, Q/cAMP). The total
levels of 2/3 subunits in the absence (101.2 8.9% of control)
or presence of SKF-38393 (118.2  10.4% of control; p  0.05,
Figure 5. Dopamine receptor activation decreases the cell-surface expression of GABAA receptors via a dynamin-dependent
pathway.A,B, Internalization of GABAA receptorswas visualized by stainingwith2/3-specific antibody in the presence of vehicle,
SKF-38393 (A), or quinpirole (B), as described inMaterials andMethods. Binding of2/3-specific antibody to the surface expressed
GABAA receptorswas visualizedusinga secondary anti-mouse IgG coupled toAlexa555 (in red),whilebindingof the sameantibody
to internalized receptorswas visualized using a secondary anti-mouse IgG coupled to Alexa488 (in green). Scale bars correspond to
10m. C, The decrease in surface2/3 subunit levels caused by SKF-38393 (SKF) was significantly attenuated in the presence of a
dynamin inhibitory peptide (SKF/DynP), but not in the presence of its scrambled control (SKF/DynPC). D, The decrease in surface
2/3 subunit levels caused by quinpirole (Q) was also significantly attenuated in the presence of a dynamin inhibitory peptide
(Q/DynP), but not by its scrambled control (Q/DynPC). Bars represent mean SEM. Statistical analysis was performed using
one-way ANOVAwith Dunnett post hoc analysis versus control (*p 0.05; **p 0.01) or paired t test ( #p 0.05; ##p 0.01).
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one-way ANOVA; n 	 5) or quinpirole
(103.5 10.3% of control, p 0.05, one-
way ANOVA with Dunnett post hoc anal-
ysis; n 	 4) were also unaffected by
8-bromo-cAMP (SKF/8BrcAMP: 107.1
12.4% of control; quinpirole/8BrcAMP:
108.3  7.2% of control, p  0.05, one-
way ANOVA; n 	 5 and n 	 4, respec-
tively, data not shown).
To further support the role of PKA in
D1R/AC signaling pathway, we treated
striatal neurons with the PKA inhibitor
KT-5720 (5 M) in the absence or pres-
ence of SKF-38393 (1 nM) for 30 min.
While PKA inhibition with KT-5720
alone had no significant effect on surface
2/3 levels (96.1  6.1% of control; p 
0.05, one-way ANOVA; n 	 3), it signifi-
cantly enhanced D1R-mediated decrease in
2/3 cell-surface expression from 87.1 
4.2% of control to 77.3  5.5% of control
( p 	 0.024, paired t test; n 	 3, data not
shown). Total 2/3 levels were unaffected in
the presence of KT-5720 (99.5  2.1% of
control, p 0.05, one-wayANOVA; n	 3)
or SKF (115.8  6.5% of control) or both
(114.78.1%ofcontrol;p0.05,one-way
ANOVA; n	 3; data not shown).
MEK/ERK1 and ERK2 signaling
D1Rs, but not D2Rs, are known to stimu-
late MAP kinases ERK1 and ERK2
(Valjent et al., 2005) via activation of an
upstream kinase,MAP kinase/ERK kinase
(MEK) (Sefton, 2001). We have observed
that SKF-38393 but not quinpirole signif-
icantly increased the phosphorylation/ac-
tivity of ERK1/2 after 30 min treatment
(data not shown). Furthermore, we found
that inhibition of MAP kinase kinase,
MEK, with PD-98059 (50 M) attenuated
the ability of SKF-38393 to decrease
GABAA receptor cell-surface levels from
87.0  3.5% (Fig. 6C, SKF) to 98.5 
Figure 6. D1R-dependent reduction of the GABAA receptor levels expressed at the cell surface is mediated by the activities of
PKA, ERK1 and ERK2, and PP2A, whereas D2R-dependent decrease is mediated by the activity of PP1. A, The effect of SKF-38393
(SKF), but not quinpirole (Q), was occluded by a direct activation of adenylyl cyclase (AC) with forskolin (SKF/F, Q/F, respectively).
B, The effect of SKF-38393 (SKF), but not quinpirole (Q), was also occluded by a direct activation of protein kinase A (PKA) with
8-bromo-cAMP (SKF/cAMP, Q/cAMP, respectively). C, The effect of SKF-38393 (SKF), but not quinpirole (Q) was attenuated by
inhibition of ERK kinases (ERK1 & 2) with PD-98059 (SKF/PD, Q/PD, respectively). D, The inhibition of protein kinase C (PKC) by
calphostin C (CC) had no effect on SKF-38393-dependent (SKF vs SKF/CC), or quinpirole-dependent (Q vs Q/CC) decrease in2/3
4
surface levels. E, Buffering of extracellular calcium with EGTA
(EGTA) had no effect on SKF-38393-dependent (SKF vs SKF/
EGTA), or quinpirole-dependent (Q vs Q/EGTA) decrease in
2/3 surface levels. F, Buffering of intracellular calcium with
BAPTA-AM (BAPTA) had no effect on SKF-38393-dependent
(SKF vs SKF/BAPTA), or quinpirole-dependent (Q vs Q/BAPTA)
decrease in2/3 surface levels.G, The decrease in surface2/3
levels caused by SKF-38393 (SKF), but not quinpirole (Q) was
abolished by a low concentration of okadaic acid (0.1 M;
SKF/OA 0.1, Q/OA 0.1, respectively), while both SKF-38393-
dependent (SKF) and quinpirole-dependent (Q) decreases
were abolished by a high concentration of okadaic acid (1 M;
SKF/OA 1, Q/OA 1, respectively).H, The effect of SKF-38393 (SKF),
but not quinpirole (Q), was significantly attenuated by fostriecin
(SKF/Fos, Q/Fos, respectively). Bars represent mean SEM. Sta-
tistical analysiswas performedusing one-wayANOVAwith either
aDunnettposthocanalysisversuscontrol(*p0.05;**p0.01)
or paired t test ( #p 0.05; ##p 0.01).
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2.5%of control ( p 0.05, paired t test, n	 7) (Fig. 6C, SKF/PD).
In contrast, PD-98059 had no significant effect quinpirole-
dependent regulation: quinpirole decreased surface 2/3 levels to
86.9 4.2%of control (Fig. 6C, Q) and to 85.9 5.5%of control
in the presence of PD-98059 ( p 0.05, paired t test, n	 6) (Fig.
6C, Q/PD). PD-98059 did not significantly affect cell-surface2/3
levels when added alone (data not shown).
PKC signaling
PKC is known to regulate surface levels of GABAA receptors in
cultured hippocampal and cortical neurons by inhibiting the re-
cyclingof internalized receptors to theplasmamembrane (Connolly
et al., 1999). To determine whether PKC is involved in modulat-
ing surface levels of GABAA receptors in cultured striatal neu-
rons, we used calphostinC (0.2M), a PKC inhibitor that inhibits
both typical and atypical isoforms of this enzyme (Kobayashi et
al., 1989). In the presence of calphostinC alone, surface2/3 levels
were unaffected (97.5  10.1% of control; p  0.05, one-way
ANOVA; n 	 5; data not shown). A significant reduction in
surface 2/3 levels by SKF-38393 to 80.7 4.7% of control ( p
0.05, one-wayANOVA;n	 5) (Fig. 6D, SKF), or by quinpirole to
85.2 3.9% of control ( p 0.05, one-way ANOVA; n	 5) (Fig.
6D, Q), was unaffected by calphostin C [72.6 5.3% of control,
p 0.05, paired t test; n	 5 (Fig. 6D, SKF/CC); and 84.8 5.1%
of control, p 0.05, paired t test; n	 5 (Fig. 6D, Q/CC)]. Total
2/3 levels remained unchanged following the treatment with cal-
phostin C alone, or in combination with SKF-38393 or quinpi-
role (data not shown). Thus, PKC activity is not required for
either D1R- or D2R-dependent regulation of surface 2/3 levels in
the embryonic striatal neurons.
Ca2-dependent signaling
Ca2 plays a fundamental role as an intracellular signal by di-
rectly regulating the activity of a large number of signaling mol-
ecules including protein kinases and phosphatases (Walaas and
Greengard, 1991), which have been previously implicated in both
D1R (Surmeier et al., 1995; Tang and Bezprozvanny, 2004;
Iwakura et al., 2008) and D2R (Surmeier et al., 1992; Aizman et
al., 2000; Tang and Bezprozvanny, 2004) signaling in striatal
neurons. To examine a possible requirement for Ca2 and Ca2-
dependent signaling pathways in the regulation of GABAA receptor
surface levels, we selectively buffered extracellular or intracellular
Ca2 before the activation of dopamine receptors. To examine
the contribution of extracellular Ca2, we applied a Ca2-
chelating agent EGTA (1 mM). We demonstrate that EGTA had
no effect on the surface levels of2/3 subunits ( p 0.05, one-way
ANOVA with Dunnett post hoc analysis; n	 5; data not shown).
Importantly, SKF-38393-dependent (88.5 1.2%of control, p
0.05, one-way ANOVAwith Dunnett post hoc analysis; n	 5) (Fig.
6E, SKF) and quinpirole-dependent (85.5 3.4% of control, p
0.05, one-way ANOVAwith Dunnett post hoc analysis; n	 4) (Fig.
6E, Q) decreases in surface 2/3 levels were unaffected by the pres-
enceofEGTA(82.55.0%ofcontrol, SKF/EGTA,and85.82.6%
of control, Q/EGTA, p 0.05, one-way ANOVAwithDunnett post
hoc analysis; n	 5 and n	 4, respectively) (Fig. 6E).We also dem-
onstrate that changes in total 2/3 levels were not statistically signif-
icant following the treatment with EGTA alone or in combination
with SKF-38393 or quinpirole (data not shown).
To buffer intracellular Ca2, we applied a high-affinity,
membrane-permeable Ca2 chelator, BAPTA-AM (25 M).
BAPTA-AM treatment alone had no effect on surface 2/3 levels
( p 0.05, one-wayANOVA; n	 3; data not shown).Neither the
SKF-38393-dependent (89.5  1.0% of control, p  0.01, one-
way ANOVA; n 	 3) (Fig. 6F, SKF), or quinpirole-dependent
(72.3 4.5% of control, p 0.05, one-way ANOVAwith Dunnett
post hoc analysis; n	 5) (Fig. 6F, Q) decrease in surface 2/3 levels
was affected by BAPTA-AM [89.5  0.7% of control, p  0.01,
one-wayANOVA;n	3 (Fig. 6F, SKF/BAPTA); and78.94.9%of
control p  0.05, one-way ANOVA; n 	 5 (Fig. 6F, Q/BAPTA)].
Total 2/3 levels were not significantly affected following treatment
withBAPTAaloneor incombinationwithSKF-38393,orquinpirole
(data not shown). Together, these data suggest that changes in
[Ca2]i andCa
2-dependent signaling proteins are not involved in
the regulation of surface GABAA receptors by D1Rs or D2Rs.
Protein phosphatase signaling
Protein phosphatases PP1 and PP2A have been shown previously
to associate with GABAA receptors (Jovanovic et al., 2004; Ter-
unuma et al., 2004). To investigate whether their activity is re-
quired for D1R- or D2R-dependent regulation of surface 2/3
levels, we incubated striatal neurons with 0.1 M okadaic acid, a
concentration sufficient to block PP2A activity, or with 1 M
okadaic acid, a concentration that inhibits both PP1 and PP2A
(Nishi et al., 1997). We demonstrate that treatments with both
0.1 and 1 M okadaic acid significantly attenuated the ability of
SKF-38393 to reduce 2/3 surface levels from 82.1  5.9% of
control ( p  0.05, one-way ANOVA; n 	 5) (Fig. 6G, SKF) to
101.6 5.6% of control, and to 95.3 6.2% of control ( p 0.05,
paired t test, n	 3, SKF/OA 0.1, or n	 4, SKF/OA 1, respectively)
(Fig. 6G). In contrast, quinpirole-dependent decrease in surface2/3
levels (87.0 2.7% of control, p 0.05, one-way ANOVA; n	 5)
(Fig. 6G, Q) was unaffected by 0.1M okadaic acid (80.6 4.7% of
control, p  0.05, paired t test, n 	 5) (Fig. 6G, Q/OA 0.1), but
significantly attenuated by 1Mokadaic acid (105.3 3.4%of con-
trol, p 0.01, paired t test, n	 5) (Fig. 6G, Q/OA 1). Okadaic acid
hadno significant effect on surface2/3 levels at either concentration
tested (data not shown). Total 2/3 levels were not significantly af-
fected following treatment with okadaic acid alone or in combina-
tion with SKF-38393 or quinpirole (data not shown).
The role of PP2Awas confirmed using a selective PP2A antag-
onist fostriecin (100 nM) (Stampwala et al., 1983). The ability of
SKF-38393 to decrease 2/3 subunit cell-surface levels (82.0 
3.3% of control, one-way ANOVA; n 	 4) (Fig. 6H, SKF) was
significantly attenuated by fostriecin (97.5 2.7%of control, p
0.05, paired t test, n 	 4) (Fig. 6H, SKF/Fos). In contrast,
quinpirole-dependent decrease in surface 2/3 levels (83.8 
5.4%ofcontrol,p0.05,one-wayANOVA;n	3) (Fig. 6H,Q)was
unaffected by fostriecin (77.8 3.0% of control, p 0.05, paired t
test, n	 3) (Fig. 6H). Thus, D1R-dependent regulation of surface
GABAA receptors operates via activation of AC/PKA signaling path-
way, ERK kinases, and PP2A, while D2R-dependent regulation re-
quires the activity of PP1 in embryonic striatal neurons.
D1R and D2R activation transiently dephosphorylates
GABAA receptors
Given that D1R- and D2R-dependent regulation of surface
GABAA receptors requires the activity of protein phosphatases
PP2A and PP1, we hypothesized that GABAA receptor themselves
may be dephosphorylated by these phosphatase to trigger their en-
docytosis, as already demonstrated in the adult striatal tissue (Kittler
andMoss, 2003; Kittler et al., 2005, 2008; Chen et al., 2006). Thus
we used a phosphorylation state-specific antibody [anti-P anti-
body (Jovanovic et al., 2004)], which selectively binds to P-Ser409
in the 1 and 3, and P-Ser410 in the 2 subunit of GABAA
receptors, to determine the state of phosphorylation of these re-
ceptors in response to D1R or D2R activation. Using quantitative
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immunoblotting, we demonstrate that
SKF caused a rapid dephosphorylation of
 subunits (75.9  4.3% of control, p 
0.05, paired t test; n 	 3) (Fig. 7A, SKF),
which was abolished in the presence of
PP2A inhibitor fostriecin (120.8 11.6%
of control, p  0.05, paired t test; n 	 3)
(Fig. 7A, SKF/Fos). Additionally, fostrie-
cin caused an apparent increase in the
basal levels of  phosphorylation to
125.3  21.9% of control ( p  0.05,
paired t test; n 	 3) (Fig. 7A, Fos). Inter-
estingly, MEK inhibitor PD-98059 (50
M) also abolished dephosphorylation of
 subunits by SKF (124.3 11.0%of con-
trol, p 0.05, paired t test; n	 3) (Fig. 7A,
SKF/PD), and produced an apparent in-
crease in  phosphorylation (125.7 
14.0% of control, p 0.05, paired t test;
n 	 3) (Fig. 7A, PD) on its own. Total
levels were not significantly affected by
SKF-38393 or any other treatment (data
not shown). Activation of D2Rs with
quinpirole caused a significant decrease
in phosphorylation of  subunit to
79.3  6.2% of control ( p  0.05,
paired t test; n 	 4) (Fig. 7B, Q). Pre-
treatment with the PP1 inhibitor oka-
daic acid (1 M) increased significantly
the basal levels of  subunit phosphory-
lation to 726.6 76.4% of control ( p
0.05, paired t test; n 	 4) (Fig. 7B, OA),
and completely abolished dephosphor-
ylation of  subunits caused by quinpi-
role (664.7  110.4% of control, p 
0.05, paired t test; n 	 4) (Fig. 7B,
Q/OA). Thus, it appears that PP2A and
PP1 dephosphorylate GABAA receptor  subunits in response
to D1R and D2R activation, respectively.
To characterize further PP1- and PP2A-mediated dephos-
phorylation ofGABAA receptors, we performed in vitro phospha-
tase assays using purified enzymes, catalytic subunit of PP1
(PP1c), PP2A (PP2A), and calcineurin, and purified phosphory-
lated GST-fusion proteins containing the intracellular TM3-4
loops of the 1-3 subunits (see Materials andMethods). In these
experiments, the initial rates of dephosphorylation of [32P]-
phospho-GST-1-3 subunits, and [32P]-phospho-DARPP-32 or
[32P]-phosphorylase a used as reference substrates, were assessed
by measuring the release of phosphate (Table 1). Compared to
the reference substrates, all three  subunits appeared to be good
substrates for PP1c and PP2A, but poor substrates for cal-
cineurin. These initial results were extended by a kinetic analysis
of [32P]-phospho-GST-1-3 dephosphorylation with PP1c and
PP2A (Table 2). Two kinetic parameters, Km (the apparent affin-
ity for substrate), and Vmax (the rate), were determined demon-
strating a high affinity and rapid dephosphorylation of all three
subunits by PP1c and PP2A.
Importantly, activation of dopamine receptors leads to a sig-
nificant but transient dephosphorylation of GABAA receptor 
subunits. We demonstrate that application of SKF-38393 (1 nM),
caused a significant decrease in phosphorylation of the  sub-
units at 10 min to 87.0  3.3% of control ( p  0.05, one-way
ANOVA; n	 3), and, at 60 min to 86.5 2.5% of control ( p
0.05, paired t test; n	 5) (Fig. 7C,D, SKF), which was reversed to
the basal levels at later time points. The application of quinpirole
(100 nM) caused a significant decrease in phosphorylation of the
 subunits within 5 min to 82.5  5.2% of control ( p  0.05,
one-way ANOVA; n 	 4), but only an apparent decrease at 60
min to 88.4 6.0%of control ( p 0.05, one-way ANOVA; n	 4)
(Fig. 7C,D, Q). Importantly, when both SKF-38393 and quinpi-
role were applied at the same time, we observed a similar tran-
sient decrease in  subunit phosphorylation to 83.7  4.0% of
control at 5 min, and to 79.9 8.0% of control at 60 min, which
was reversed to the basal levels at later time points ( p  0.05,
one-way ANOVA; n	 4) (Fig. 7C,D, SKF/Q).
Thus, dopamine receptor activity exerts its powerful control
of inhibitory synaptogenesis in the developing striatum by regu-
lating the levels of GABAA receptors expressed at the cell surface
through a mechanism that involves transient dephosphorylation
of these receptors.
Discussion
With its essential role as the major input area to the basal ganglia
and its dysfunction in the pathogenesis of diseases such as
Parkinson’s and Huntington’s diseases, the striatum represents
one of the primary subjects of scientific interest. While there is
increasing research into the function of the adult striatum, very
little work has focused on its development. The striatum receives
considerable dopaminergic input from the substantia nigra early
Figure 7. D1R and D2R activation leads to a transient dephosphorylation of GABAA receptor  subunits. A, Treatment with
SKF-38393 (1 nM, 30 min) led to a decrease in  subunit phosphorylation (SKF), which was abolished by fostriecin (SKF/Fos) or
PD-98059 (SKF/PD). Both inhibitors alone caused small but insignificant increases in the basal phosphorylation state of the 
subunits (Fos, PD, respectively). A representative immunoblot is shownbelowthebargraph.B, Treatmentwithquinpirole (100nM,
30 min) also led to a decrease in subunit phosphorylation (Q), which was abolished by okadaic acid (Q/OA). Okadaic acid alone
caused a prominent increase in the basal phosphorylation state of the  subunits (OA). A representative immunoblot is shown
below the bar graph. C,D, The time course of changes in the phosphorylation state of the subunits in the presence of SKF-38393
(SKF), quinpirole (Q), or both (SKF/Q). Representative immunoblots (C) and graphs showing percentage values normalized to the
appropriate controls treated with the vehicle (100%; D) show a transient decrease in the phosphorylation state of the subunits
at an early time point (5–10min) and a later time point (60min) of incubation with either SKF-38393 (SKF, in red), quinpirole (Q,
in green), or both (SKF/Q, in blue). Values represent mean SEM. Statistical analysis was performed using one-way ANOVAwith
either a Dunnett post hoc analysis versus control (*p 0.05) or paired t test ( #p 0.05).
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in development, and the evidence suggests that dopamine may
play an important role. For example, in utero exposure to cocaine
profoundly affects development of neuron dendrites (Jones et al.,
1996; Levitt et al., 1997) through the activation of dopamine
receptors (Jones et al., 2000; Stanwood and Levitt, 2007).Herewe
present evidence for a novel role of dopamine in the formation of
GABAergic synapses between embryonic precursors of striatal
medium spiny neurons, and uncover the underlying signaling
mechanisms.
We first demonstrate the presence of dopaminergic (TH)
fibers and terminals in the embryonic E17 striatum in vivo, and
estimate the in vivo levels of tissue dopamine using HPLC.More-
over, we reveal that dopamine receptors (both D1Rs and D2Rs)
are coexpressed in the large population of neurons within the
embryonic striatum. Our experiments further demonstrate that
activation of these receptors produces a robust decrease in the
number of GABAergic synaptic contacts as indicated by a reduc-
tion in colocalization between GABAA receptor-positive clusters
and VIAAT-1/FM1-43FX-positive presynaptic nerve terminals.
Similar type of analysis has been used extensively to study forma-
tion of GABAergic synapses (Chih et al., 2005; Dong et al., 2007;
Yu et al., 2007). Furthermore, our functional experiments dem-
onstrate that the observed mislocalization of synaptic elements
leads to a reduction in the frequency of
spontaneous GABAA receptor-mediated
synaptic potentials (mIPSPs), as well as a
reduction in their amplitudes. The latter
also correlates with a reduction in the
number of GABAA receptors present at
the postsynaptic membrane (Nusser et
al., 1997, 1998). Accordingly, immunocy-
tochemical analysis of GABAA receptor-
positive clusters, as well as biochemical
measurements of cell-surface levels of
GABAA receptors using ELISA, clearly
demonstrates that this is indeed the case.
However, it is important to note that de-
spite the reduction in size, the overall
number of postsynaptic GABAA receptor
clusters, as well as the size and number of
presynaptic VIAAT-1-positive terminals,
remains unaltered. This suggests that
formation and/or stability of functional
GABAergic synapses may depend on the
size of GABAA receptor clusters present at
the postsynaptic membrane, in addition
to the type of GABAA receptors that form
these clusters. In support of this hypothe-
sis is the observation that, in many brain
regions, extrasynaptic clusters of GABAA
receptors are significantly smaller than
their synaptic counterparts (Christie et al.,
2002a,b). Overall, the ability of striatal neu-
rons to form functional synaptic contacts
with each other appears to be restricted
by dopamine during development. Do-
pamine is known to decrease the number
of glutamatergic synapses present on
D2R-containing medium spiny neurons
in the adult striatum, since the depletion
of dopamine in the rat models of Parkin-
son’s disease leads to an increase in the
number of synapses (Day et al., 2006). To-
gether with these observations, our experiments suggest that the
effects of dopamine on the structure of synaptic contacts may be
widespread in the developing striatum as well as in the adult
striatum. In addition, given that dopamine receptor activation
leads to a reduction in cell-surface levels of GABAA receptors,
which is concomitant with a reduction in the number of
GABAergic synapses, we hypothesize that GABAA receptors pro-
mote development ofGABAergic synapses not only as the “build-
ing blocks” of GABAergic synapses, but also through their
activity. Indeed, GABAA receptor activity has been suggested to
play an important role in formation and/or stabilization of syn-
apses in the adult neurons (Li et al., 2005; Chattopadhyaya et al.,
2007).
Dopamine-dependent reduction in the levels of GABAA re-
ceptors expressed at the cell surface, which we demonstrate is due
to increased endocytosis of these receptors, and a decrease in
GABAergic currents, appear to be preserved in the striatum until
adulthood, when D1Rs activation causes similar effects (Flores-
Hernandez et al., 2000; Herna´ndez-Echeagaray et al., 2007).
Moreover, in other brain regions, for example, in the nucleus
accumbens (Chen et al., 2006) and hippocampus (Graziane et al.,
2009), D2Rs cause a decrease in cell-surface expression and
GABAA receptor-mediated currents. It is intriguing however,
Figure 8. Functional cross talk between D1R and D2R signaling pathways regulating GABAA receptors in the embryonic striatal
neurons. Activation of D1Rwith SKF-38393 (in red) leads to activation of adenylyl cyclase (AC) resulting in activation of conceivably
two segregated pools of protein kinase A (PKA). The first pool of PKA is associated with GABAA receptors leading to a rapid
phosphorylation of GABAA receptors (i). The second pool of PKA is more distal and unable to associate with GABAA receptors. This
pool of PKA directly phosphorylates and activates protein phosphatase 2A (PP2A, ii). Activated PP2A associates with and dephos-
phorylates GABAA receptors, promoting their internalization from the cell surface (iii). The ability of PP2A to dephosphorylate
GABAA receptors is likely to be enhanced due to ERK1/2-mediated phosphorylation and activation of PP2A (iv). ERK1/2 can be
activated by twodifferent signaling pathways both involving PKA. First, PKA candirectly phosphorylate and thus inactivate striatal
enriched phosphatase (STEP, v). In this way, STEP is no longer able to dephosphorylate and deactivate ERK1/2. Second, PKA can
lead to the activation of DARPP-32, an inhibitor of protein phosphatase 1 (PP1, vii). Inactivated PP1 cannot dephosphorylate and
activate STEP, which is then unable to dephosphorylate ERK1/2 (viii). Both of these pathways lead to an increase in the level of
phosphorylated ERK1/2, which acts on PP2A to promote dephosphorylation of GABAA receptors. Activation of D2Rs by quinpirole
(in green) leads to a dephosphorylation of GABAA receptors and their internalization by inhibiting AC. Inhibition of AC leads to a
reduction in the activation of PKA and consequently to a reduction in PKA-mediated phosphorylation of GABAA receptors (i). At the
same time however, inhibition of ACmay lead to a decrease in DARPP-32 activity and thus activation of PP1 (vii). Activated PP1 is
then capable of associating with GABAA receptors and mediating their dephosphorylation and subsequent internalization (ix).
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that the functionally opposing signaling pathways coupled to
D1Rs and D2Rs, which are clearly segregated to different types of
medium spiny neurons in the adult striatum (Surmeier et al.,
2007), operate jointly within their embryonic counterparts to
produce quantitatively similar changes in GABAA receptor sur-
face levels as demonstrated here.
To elucidate the signaling players underpinning this regula-
tion, we first demonstrate that D1Rs decrease the cell-surface
expression of GABAA receptors and their phosphorylation state
through an intracellular signaling pathway involving AC/PKA,
ERK1/2, and PP2A (Figs. 6–8). The question remains as to how
AC, PP2A, and ERK1/2 can act in concert to cause the observed
dephosphorylation and endocytosis of GABAA receptors. One
possiblemechanism is that D1Rs decrease the phosphorylation of
GABAA receptors through the activity of PP2A (Fig. 8). Indeed
this has been shown to occur in other systems (Jovanovic et al.,
2004), and PP2A can be activated by D1Rs through PKA-
mediated phosphorylation (Ahn et al., 2007). However, PKA is
also known to associate with GABAA receptors and phosphory-
late  subunits directly (Brandon et al., 2003). Therefore it seems
likely that the balance between these two signaling pathways,
possibly mediated by two spatially segregated pools of PKA, will
determine the phosphorylation state of GABAA receptors, but is
this balance critical for the regulation of GABAA receptor endo-
cytosis? Although we demonstrate a clear correlation between
D1R- and D2R-dependent reduction in both GABAA receptor
cell-surface expression and phosphorylation state, it must be
noted that the former is long lasting, while the latter is only tran-
sient. Thus, the receptor dephosphorylation may be required
only for the initiation of endocytosis, but not for the subsequent
maintenance of the appropriate levels of GABAA receptors at the
cell surface. In the adult tissue, dynamin-dependent endocytosis
of GABAA receptors has been reported to depend on their phos-
phorylation state (Kittler et al., 2000, 2005, 2008). Similar
phosphorylation-dependent mechanisms have been shown to
underlie D3R-induced internalization of GABAA receptors in the
adult nucleus accumbens (Chen et al., 2006).
The role of ERK1 and ERK2 kinases in D1R-dependent regu-
lation of surface GABAA receptors is intriguing. As schematically
depicted in the Figure 8, D1Rs may regulate the activity of ERK1
and ERK2 kinases through an inhibition of the striatal-enriched
tyrosine phosphatase STEP (Paul et al., 2000; Valjent et al., 2005;
Braithwaite et al., 2006b), which was previously shown to de-
phosphorylate and inactivate ERK kinases (Braithwaite et al.,
2006b; Venkitaramani et al., 2009). D1R-triggered increase of
ERK activity may also be mediated through DARPP-32-dependent
and -independent mechanisms (Gerfen et al., 2008). Namely, D1Rs
can lead to an activation of DARPP-32 through a PKA- and/or
PP2A-dependent signaling mechanism (Svenningsson et al., 2004)
resulting in a decrease in the activity of PP1. This could further lead
to an increase in STEP phosphorylation, which is concomitant with
an inhibition of its activity and consequent stimulation of ERK ki-
nases. Additionally, DARPP-32 appears to be required for an in-
crease in phosphorylation of MEK, a dual specificity kinase that
directly phosphorylates and thus activates ERK kinases (Valjent et
al., 2005). A possible DARPP-32-independent mechanismmay oc-
cur through a PKA-dependent phosphorylation of STEP, which
would decrease its activity and consequently stimulate the activity of
ERK kinases (Braithwaite et al., 2006b). Although ERK kinases can
be activated in a number of ways by D1Rs, it is unclear how this
activation impinges on the regulation of surface GABAA receptors.
We hypothesize that activated ERK kinases may stimulate PP2A
(Belcher et al., 2005) to dephosphorylateGABAA receptors and trig-
ger their internalization. In support of this hypothesis is the obser-
vation that inhibitionofERKkinasesbyPD98509notonlyabolishes
dephosphorylation of  subunits by D1Rs, but also increases their
phosphorylation on its own. A possible role of STEP in GABAA
receptor regulation is interesting since it has been previously shown
to regulate endocytosis of both NMDA and AMPA receptors
(Braithwaite et al., 2006a; Zhang et al., 2008).
We have demonstrated that D2R-dependent decreases in both
phosphorylation and cell-surface expression of GABAA receptor
aremediated by PP1 (Figs. 6–8). D2Rs, by virtue of their ability to
decrease PKA activity through inhibition of AC, may lead to a
dephosphorylation of DARPP-32 (Nishi et al., 1997). At the same
time, reduced activity of PKA may lead to a reduction in the
activity of PP2A (Ahn et al., 2007) resulting in an increase in
phosphorylation of DARPP-32 at the phosphorylation site,
which converts this protein into an inhibitor of PKA (Bibb et al.,
1999). The overall effect of these changes may be an increase in
the activity of PP1 and a corollary inhibition of PKA. This may
lead to a decrease in phosphorylation of GABAA receptors by PP1
as shown previously (Kanematsu et al., 2006). Thus, DARPP-32
and STEP may act as signaling integrators of D1R- and D2R-
signaling pathways regulating phosphorylation and surface ex-
pression of GABAA receptors in the embryonic striatal neurons.
In summary, tonic activity of dopamine receptors regulates for-
mationofGABAergic synapses in thedeveloping striatum, at least in
part, through phosphorylation-dependent changes in cell-surface
expression ofGABAA receptors. The effects of dopamine and conse-
quences of dopamine-depletion on the structure ofGABAergic syn-
apses in the adult striatum await future investigations.
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